The Peptide Boom Is Getting Out of Hand The Atlantic The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions of the Federal Food, Drug, and Cosmetic Act (FDCA).*